SEI Investments
HBIO icon

SEI Investments’s Harvard Bioscience HBIO Stock Holding History

SEI Investments’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,227
Closed -$12.6K – 2837
2025
Q1 		$12.6K Hold
2,227
– – ﹤0.01% 2747
2024
Q4 		$47K Buy
+2,227
New +$51.2K ﹤0.01% 2672
2022
Q2 		– Sell
-7,485
Closed -$465K – 2678
2022
Q1 		$465K Sell
7,485
-2,087
-22% -$123K ﹤0.01% 2119
2021
Q4 		$675K Buy
9,572
+983
+11% +$69.9K ﹤0.01% 1992
2021
Q3 		$599K Buy
8,589
+3,170
+58% +$252K ﹤0.01% 1990
2021
Q2 		$451K Buy
+5,419
New +$383K ﹤0.01% 2148
2018
Q3 		– Sell
-12
Closed -$1K – 2872
2018
Q2 		$1K Sell
12
-126
-91% -$6.45K ﹤0.01% 3459
2018
Q1 		$7K Buy
138
+51
+59% +$2.29K ﹤0.01% 2980
2017
Q4 		$3K Buy
87
+13
+18% +$439 ﹤0.01% 3044
2017
Q3 		$3K Buy
74
+46
+164% +$1.36K ﹤0.01% 2923
2017
Q2 		$1K Sell
28
-9
-24% -$223 ﹤0.01% 2941
2017
Q1 		$1K Buy
37
+8
+28% +$230 ﹤0.01% 2800
2016
Q4 		$1K Buy
+29
New +$738 ﹤0.01% 2803
2015
Q3 		– Sell
-17
Closed -$1K – 2529
2015
Q2 		$1K Sell
17
-2
-11% -$114 ﹤0.01% 2172
2015
Q1 		$0 Hold
19
– – ﹤0.01% 2292
2014
Q4 		$0 Buy
+19
New +$905 ﹤0.01% 2226

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's HBIO Position: Q2 2025 in Review

SEI Investments sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 2,227 shares — an estimated $12.6K sold.

SEI Investments first reported a position in HBIO in Q4 2014 and held it in 16 quarters. The position peaked at $675K in Q4 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • SEI Investments reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • SEI Investments sold 2,227 Harvard Bioscience shares in Q2 2025, an estimated $12.6K.
  • SEI Investments first reported a position in Harvard Bioscience in Q4 2014 and held it in 16 quarters.
  • SEI Investments's Harvard Bioscience position peaked at $675K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on SEI Investments's 13F filing for Q2 2025, filed 14 Aug 2025.